SALIX PHARM DEL SLXP (NASDAQ)

(RALEIGH, N.C.)Salix Pharmaceuticals Ltd., a drug developer, said late Monday it priced an offering of $55 million in convertible senior notes due 2028. Salix, which focuses on gastrointestinal d...READ MORE

(RALEIGH, N.C.)Drug developer Salix Pharmaceuticals Ltd. said Monday it will issue $50 million in convertible senior notes to raise funds. The notes will be due in 2028. Salix said it may use the...READ MORE

(RALEIGH, N.C.) Drug developer Salix Pharmaceuticals Ltd. said Wednesday Novel Laboratories is challenging the patent on the company's bowel cleansing drug Moviprep. The drug is licensed to ...READ MORE

(RALEIGH, N.C.)Drug developer Salix Pharmaceuticals Ltd. said Thursday that Dr Falk Pharma granted it a license to its family of budesonide products in the U.S. The news sent Salix shares up 47 c...READ MORE

Among the stock activity stories for Tuesday, March 4, from the AP Financial News: NEW YORK (AP) _ Clearwire Corp. shares slid Tuesday on the heels of its lackluster fourth-quarter...READ MORE

(NEW YORK)Shares of drug developer Salix Pharmaceuticals Ltd. fell to their lowest point in nearly five years Tuesday after the company said it swung to a fourth-quarter loss and its 2008 lo...READ MORE

(RALEIGH, N.C.)Salix Pharmaceuticals Ltd. said Monday it submitted an application to the Food and Drug Administration for marketing approval of its product granulated mesalamine to treat a type o...READ MORE